HeartCare Medical’s Intracranial Drug‑Eluting Stent Gets NMPA Filing Nod
Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609) announced that China’s National Medical Products Administration...
HeartCare Medical Technology
Shanghai HeartCare Medical Technology Receives NMPA Approval for Embolization Stent
China’s National Medical Products Administration (NMPA) has granted marketing approval to Shanghai HeartCare Medical Technology...
Shanghai HeartCare Medical Secures Taiwan Approval for Homegrown Femoral Artery Occluder
Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609), a leading player in the Chinese medical...